Market open · Delayed intraday data · 12:56 PM ET
Last update: Oct 28, 2026, 12:52 PM ET
Cencora, Inc.
$325.53▲ 0.05% today
Market Open

Why Cencora, Inc. (COR) stock moved

Updated Oct 28, 2026

Cencora, Inc. (COR) shares rose 0.0% to $325.53 as of October 28, 2026, a slight gain from the prior close of $325.37. BestStocks flagged the session as a major change for COR. The move is tied to a new SEC filing. Below, we break down what changed for COR, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

SEC Filing

Cencora, Inc. (COR) filed a new 8-K on 2026-10-21. The filing contents were not detailed in available sources. Monitor Cencora's earnings announcement on 2026-11-04 for guidance and results commentary that may clarify the significance of the 8-K filing.

This summary describes the catalyst and move as first detected on Oct 21, 2026, 10:20 AM EDT; the stock has continued trading since, so the current price and percentage move (shown above) may be larger or smaller than the figures here.
FilingsWeak confidence
Rel. volume
0.3×
Below Avg
Vs peers
—
No comparable peers
Market cap
$62.1B
New York Stock Exchange
Analyst target
$358
+9.9% vs price
Price chart
Sep 28 – Oct 28
NFNNNNNNE$300$322$344Sep 28Oct 6Oct 13Oct 21Oct 28
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Cencora, Inc. investors

For Cencora, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive 0.0% session move; Cencora, Inc. (COR) moved +3.85% from $296.57 to $307.99 on 2026-07-16. Weighing against that: New SEC filing — review for material disclosures; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $357.75, implying +9.9% upside from $325.53. BestStocks rates the overall signal quality weak (28/100). With earnings roughly 7 days out, the next report is the most likely near-term test of the move.

COR price reaction

COR last traded at $325.53, up $0.16 (+0.05%) from the previous close of $325.37. The session traded on 0.3× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $300.25 and $343.27, and it currently sits about 59% of the way up that band.

Bullish and bearish analyst opinions on Cencora, Inc. (COR)

The consensus analyst price target on Cencora, Inc. (COR) is $357.75, 9.9% above the recent $325.53. Over the past 90 days analysts logged 0 upgrades, 10 maintains, and 0 downgrades. Here is how the bullish and bearish cases on COR line up.

The bullish case

  • Wall Street's consensus price target of $357.75 implies +9.9% upside from $325.53.
  • The Street's most bullish target is $400.00 (+22.9%).
  • Positive 0.0% session move.
  • Cencora, Inc. (COR) moved +3.85% from $296.57 to $307.99 on 2026-07-16.
  • Positive price momentum.

The bearish case

  • The bearish case is comparatively thin on recent signals; the main risk is that the climb toward the $357.75 consensus target has to be earned, and any of the risks BestStocks tracks could weigh on the shares.
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Oct 28, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $358+9.9%
= 10 maintains
Baird maintained Outperform · 2026-10-22
SEC filings watch
8-K2026-10-21
Material event — review for impact
high
8-K2026-09-25
Material event — review for impact
high
8-K2026-08-14
Material event — review for impact
high
8-K2026-08-12
Material event — review for impact
high
Peer context
COR+0.0%

Previous notable changes for COR

News2026-10-21-0.8%
Cencora announced $2.4 billion acquisition of American Oncology Network to expand oncology service capabilities.
News2026-10-19-0.3%
IFP Advisors Inc Purchases 14,078 Shares of Cencora, Inc. $COR
News2026-10-17
Cencora (NYSE:COR) and Option Care Health (NASDAQ:OPCH) Financial Contrast
News2026-10-14+1.8%
AI-driven prescription volume increases and automated prescribing pilots position COR to capture operational leverage gains.
Upcoming catalysts & outlook
Next earnings
2026-11-04 (est.)
in 7 days
Thesis shift
Neutral / Mixed
bullish signal
Risk level
Low
from change events

Frequently asked questions about COR

Why did Cencora, Inc. (COR) stock move?

COR rose 0.0% to $325.53. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.

How much did COR stock rise?

COR gained 0.05% ($0.16) versus the prior close of $325.37, last trading at $325.53 on 0.3× average volume.

When is Cencora, Inc.'s next earnings date?

COR's next earnings report is estimated for 2026-11-04 — about 7 days away.

What is the analyst price target for COR?

The consensus analyst price target for COR is $357.75, about 9.9% above the current $325.53. Over the past 90 days, analysts recorded 0 upgrades, 10 maintains, and 0 downgrades.

How BestStocks tracks COR

This page is generated automatically by BestStocks' change-detection system after a new SEC filing was detected and verified against independent data sources. It draws on 20 tracked change events for COR, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of October 28, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.